Sandra Milligan - 01 May 2023 Form 4 Insider Report for Organon & Co. (OGN)

Role: Head of Research & Development
Signature: /s/ Tarnetta V. Jones, as Attorney-in-Fact for Sandra Milligan
Issuer symbol: OGN
Transactions as of: 01 May 2023
Net transactions value: -$20,344
Form type: 4
Filing time: 03 May 2023, 19:06:56 UTC
Previous filing: 04 Apr 2023
Next filing: 08 May 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	OGN	Common Stock	Options Exercise		+1,899	+7.7%		26,609	01 May 2023	Direct	F1
transaction	OGN	Common Stock	Tax liability	$20,344	-826	-3.1%	$24.63	25,783	01 May 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	OGN	Restricted Stock Units	Options Exercise	$0	-1,899	-100%	$0.000000^*	0	01 May 2023	Common Stock	1,899		Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU. On May 1, 2022, 50% of the RSUs vested, and on May 1, 2023, the remaining 50% of the RSUs vested.